The company’s revenues increased more than 65 times year on year.
The American pharmaceutical company Moderna, which developed a vaccine against the new coronavirus, recorded over $4 billion in revenue for the past quarter. As follows from the quarterly financial statements published on Thursday, the company’s revenues increased more than 65 times year on year.
Thus, for the three-month reporting period ended June 30, the company’s revenue amounted to $4,354 billion. For the six-month period, data on this indicator amounted to $6.291 billion. For the same periods last year, the company’s revenue was $67 million and $75 million, respectively.
The company’s net profit for the three-month period amounted to $2.78 billion. During the same period last year, Moderna suffered losses of $117 million. For six months, the company earned $4 billion, although losses were recorded for $241 million last year during the reporting period.
Moderna is one of the three manufacturers of the coronavirus vaccine in the United States. Along with it, a consortium of the American company Pfizer and its German partner BioNTech developed their vaccines, as well as Moderna, which produces a two-component drug, and Johnson & Johnson, a division of which Janssen produces a one-component drug.